Search
Search
About
Log in
Join
Experiences with
Atezolizumab
Posts
Communities
64 public posts
Filter results
atezolizumab Injection
Hi all, I’ve read online that some sclc patients are getting
atezolizumab
immunotherapy by injection. It was first used in March 2024 in Newcastle. There doesn’t seem to be much other information.
Hi all, I’ve read online that some sclc patients are getting
atezolizumab
immunotherapy by injection. It was first used in March 2024 in Newcastle. There doesn’t seem to be much other information.
Killiancon
in
The Roy Castle Lung Cancer Foundation
2 months ago
For Neuroendocrine, Small Cell or Mixed PCa/NEPC Cancer, How to Find Out which Immunotherapy is the best to use
MO wants to use Keytruda but it failed in trials isn’t Dostarlimab or
atezolizumab
better?
MO wants to use Keytruda but it failed in trials isn’t Dostarlimab or
atezolizumab
better?
Shorehousejam
in
Advanced Prostate Cancer
4 months ago
ESMO 2024: Cabozantinib plus Atezolizumab versus 2nd novel hormonal therapy inmetastatic CRPC, overall survival results of CONTACT-02 Study
https://www.urotoday.com/conference-highlights/esmo-2024/esmo-2024-prostate-cancer/154863-esmo-2024-cabozantinib-plus-
atezolizumab
-versus-2nd-novel-hormonal-therapy-in-patients-with-metastatic-castration-resistant-prostate-cancer-final-overall-survival-results-of-the-phase-iii-randomized-contact-02-study.html
https://www.urotoday.com/conference-highlights/esmo-2024/esmo-2024-prostate-cancer/154863-esmo-2024-cabozantinib-plus-
atezolizumab
-versus-2nd-novel-hormonal-therapy-in-patients-with-metastatic-castration-resistant-prostate-cancer-final-overall-survival-results-of-the-phase-iii-randomized-contact-02-study.html
Maxone73
in
Advanced Prostate Cancer
2 days ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Chemo-Free Triplet Yields 68% Response Rate in Richter Transformation
Atezolizumab
, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): A multicentre, single-arm, phase 2 trial. [i]The Lancet. Oncology[/i], S1470-2045(24)00396-6.
Atezolizumab
, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): A multicentre, single-arm, phase 2 trial. [i]The Lancet. Oncology[/i], S1470-2045(24)00396-6.
Classicaljazz
in
CLL Support
2 days ago
#AskChatGPT : list of immunotherapy drugs for prostate cancer
Atezolizumab
(Tecentriq):
Atezolizumab
is a checkpoint inhibitor that targets PD-L1 (programmed death-ligand 1). It has been studied in combination with other therapies for advanced prostate cancer in clinical trials.
Atezolizumab
(Tecentriq):
Atezolizumab
is a checkpoint inhibitor that targets PD-L1 (programmed death-ligand 1). It has been studied in combination with other therapies for advanced prostate cancer in clinical trials.
God_Loves_Me
in
Advanced Prostate Cancer
5 months ago
Neuroendocrine PCa
I was treated with 4 rounds of
atezolizumab
/carboplatin/etoposide (chemotherapy and immunotherapy). A pet/CT scan shows it was effective, and I fared better than I expected going in, but definitely have fatigue and weakness.
I was treated with 4 rounds of
atezolizumab
/carboplatin/etoposide (chemotherapy and immunotherapy). A pet/CT scan shows it was effective, and I fared better than I expected going in, but definitely have fatigue and weakness.
CharlieBC
in
Advanced Prostate Cancer
10 months ago
Good news from the ATTLAS trial for patients with EGFR mutations and ALK translocations.
Treatment with
atezolizumab
, bevacizumab, paclitaxel, and carboplatin (ABCP) was significantly more effective than pemetrexed plus carboplatin or cisplatin https://dailynews.ascopubs.org/do/
atezolizumab
-bevacizumab-and-chemotherapy-improves-pfs-egfr---alk--mutated-nsclc-after?
Treatment with
atezolizumab
, bevacizumab, paclitaxel, and carboplatin (ABCP) was significantly more effective than pemetrexed plus carboplatin or cisplatin https://dailynews.ascopubs.org/do/
atezolizumab
-bevacizumab-and-chemotherapy-improves-pfs-egfr---alk--mutated-nsclc-after?
Denzie
Volunteer
in
Lung Cancer Support
11 months ago
CDK 12 mutation and Immunotherapy
I have the CDK12 mutation which is apparently known to be a drug target or to predict sensitivity to
Atezolizumab
(Tecentriq PD-1 Checkpoint Inhibitor), hence there is open Immunotherapy trial called BoB (NCT03767075). I meet the trial doctor next week.
I have the CDK12 mutation which is apparently known to be a drug target or to predict sensitivity to
Atezolizumab
(Tecentriq PD-1 Checkpoint Inhibitor), hence there is open Immunotherapy trial called BoB (NCT03767075). I meet the trial doctor next week.
MikeMartin
in
Advanced Prostate Cancer
8 months ago
Genitourinary Cancers Symposium Meeting Coverage, MedPage Today, January 2024
108464 [i]
Another Prostate Cancer Screening Candidate Outperforms Standard PSA Testing: Multiparametric Stockholm3 avoided far more unnecessary biopsies without sacrificing sensitivity, January 28, 2024:
[/i] https://www.medpagetoday.com/meetingcoverage/mgucs/108457 [i]
Cabozantinib Plus
108464 [i]
Another Prostate Cancer Screening Candidate Outperforms Standard PSA Testing: Multiparametric Stockholm3 avoided far more unnecessary biopsies without sacrificing sensitivity, January 28, 2024:
[/i] https://www.medpagetoday.com/meetingcoverage/mgucs/108457 [i]
Cabozantinib Plus
cujoe
in
Fight Prostate Cancer
8 months ago
NGS Test/Next-Generation Sequencing Important to have done.
In May of 2022, with my 15-3 at 70, he wanted to put me in a trial for XL092 alone or with
ATEZOLIZUMAB
- Tecentriq. At this time, I asked for testing to make sure my original dx had not changed. The only test he did was for the P13k mutation, which came back neg.
In May of 2022, with my 15-3 at 70, he wanted to put me in a trial for XL092 alone or with
ATEZOLIZUMAB
- Tecentriq. At this time, I asked for testing to make sure my original dx had not changed. The only test he did was for the P13k mutation, which came back neg.
Hopeful4Cure
in
SHARE Metastatic Breast Cancer
6 months ago
advice re treatemnt t
Looking for a bit of advice re my mum who is based in the uk At 77, She was diagnosed with stage 4 lung cancer in Dec 2022, with g12c mutation January she started
Atezolizumab
.
Looking for a bit of advice re my mum who is based in the uk At 77, She was diagnosed with stage 4 lung cancer in Dec 2022, with g12c mutation January she started
Atezolizumab
.
Jill75
in
The Roy Castle Lung Cancer Foundation
1 year ago
CONTACT-02 Phase III: Cabozantinib-Atezolizumab combination works well in mCRPC with soft tissue metastasis
https://www.urotoday.com/video-lectures/asco-gu-2024/video/mediaitem/3890-contact-02-phase-iii-trial-findings-on-cabozantinib-
atezolizumab
-combination-in-mcrpc-neeraj-agarwal.html
https://www.urotoday.com/video-lectures/asco-gu-2024/video/mediaitem/3890-contact-02-phase-iii-trial-findings-on-cabozantinib-
atezolizumab
-combination-in-mcrpc-neeraj-agarwal.html
Maxone73
in
Advanced Prostate Cancer
7 months ago
26 yrs lady dx with high grade neuroendocrine colon carcinoma with mets to nodes, ovaries. omentum, liver and bones. NEED ADVICE URGENTLY
Current Medical plan is to undergo immunotherapy (
Atezolizumab
+ Durvalumab) and chemo (Carboplatin + Eto poside). In spite of all these, she is in great spirit, willing to fight it out.
Current Medical plan is to undergo immunotherapy (
Atezolizumab
+ Durvalumab) and chemo (Carboplatin + Eto poside). In spite of all these, she is in great spirit, willing to fight it out.
Soumen79
in
Colon Cancer Connected
1 year ago
Prostate cancer morphed into NEPC
Now I'm on carboplatin, etoposide and
Atezolizumab
- chemotherapy and immunotherapy. The following article from Healthline is a great description of what took place, and possibly why.
Now I'm on carboplatin, etoposide and
Atezolizumab
- chemotherapy and immunotherapy. The following article from Healthline is a great description of what took place, and possibly why.
CharlieBC
in
Advanced Prostate Cancer
1 year ago
BIOMARKER TESTING
Her lung tumor is currently stable and I want to get options if her current immunotherapy (
atezolizumab
every three weeks) becomes ineffective. There are several chemotherapy options, such as lurbinectedin (she was in a clinical trial for this drug, but was not selected to receive the drug).
Her lung tumor is currently stable and I want to get options if her current immunotherapy (
atezolizumab
every three weeks) becomes ineffective. There are several chemotherapy options, such as lurbinectedin (she was in a clinical trial for this drug, but was not selected to receive the drug).
Info911
in
The Roy Castle Lung Cancer Foundation
1 year ago
COSMIC-021 trial
Cabozantinib plus
atezolizumab
showed promising antitumour activity in patients with metastatic castration-resistant prostate cancer after novel hormonal therapy with an acceptable safety profile, supporting further evaluation of this combination. https://www.thelancet.com/journals/lanonc/article/PIIS1470
Cabozantinib plus
atezolizumab
showed promising antitumour activity in patients with metastatic castration-resistant prostate cancer after novel hormonal therapy with an acceptable safety profile, supporting further evaluation of this combination. https://www.thelancet.com/journals/lanonc/article/PIIS1470
spw1
in
Advanced Prostate Cancer
2 years ago
outcome
My husband has just had his second infusion of
Atezolizumab
/Bevacizumab, and is feeling awful. The initial infusion caused fatigue and some sickness but he is now experiencing chills, a bad cough, sickness, lack of appetite. He feels if this reaction is repeated in future infusions he will stop.
My husband has just had his second infusion of
Atezolizumab
/Bevacizumab, and is feeling awful. The initial infusion caused fatigue and some sickness but he is now experiencing chills, a bad cough, sickness, lack of appetite. He feels if this reaction is repeated in future infusions he will stop.
nashy2
Caregiver
in
Blue Faery Liver Cancer
2 years ago
Patient experience of Atezolizumab (Tecentriq)
Atezolizumab
(Tecentriq) will shortly be assessed by the Scottish Medicines Consortium (SMC) for use in NHSScotland, and we have been invited to provide a Patient Group Submission for the medicine. We are therefore trying to gather some patient experience quotes.
Atezolizumab
(Tecentriq) will shortly be assessed by the Scottish Medicines Consortium (SMC) for use in NHSScotland, and we have been invited to provide a Patient Group Submission for the medicine. We are therefore trying to gather some patient experience quotes.
NicF4
Roy Castle
in
The Roy Castle Lung Cancer Foundation
2 years ago
Exelixis Clinical trial XL091 pill and Tecentriq (Atezolizumab)
Anyone with advanced breast cancer er/pr+, her2 neg, asked to do this trial? I am a bit concerned because I was dx with luminal A in 2016 and had a lumpdectumyin left breast. Found lymphnodes too. Had 12 rounds of chemo and 18 days of rads. Was on anastrozle until Dec of 2019 with progression, mets.
Anyone with advanced breast cancer er/pr+, her2 neg, asked to do this trial? I am a bit concerned because I was dx with luminal A in 2016 and had a lumpdectumyin left breast. Found lymphnodes too. Had 12 rounds of chemo and 18 days of rads. Was on anastrozle until Dec of 2019 with progression, mets.
Hopeful4Cure
in
SHARE Metastatic Breast Cancer
2 years ago
Neuroendocrine Prostate Cancer [NEPC]
First-Line
Atezolizumab
plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer. N Engl J Med 2018;379:2220-9. [Crossref] [PubMed] Paz-Ares L, Dvorkin M, Chen Y, et al.
First-Line
Atezolizumab
plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer. N Engl J Med 2018;379:2220-9. [Crossref] [PubMed] Paz-Ares L, Dvorkin M, Chen Y, et al.
pjoshea13
in
Advanced Prostate Cancer
3 years ago
1
2
...
4
Next page
Filter results
Clear filters
Posted in
All communities
Advanced Prostate Cancer
26 results
Lung Cancer Support
9 results
The Roy Castle Lung Cancer Foundation
8 results
View top 10 communities
Sort by
Most Relevant
Newest